Dr. Nathan Treff featured in March ’14 issue of Chemical & Engineering News

NeXgen-ARTComprehensive chromosome screening (CCS) represents one of the most important breakthroughs in assisted reproductive technology.  RMANJ has been at the forefront of CCS research, developing the most accurate and clinically validated method in the world. Our continued dedication to advance the technology of CCS has now taken us into the realm of next-generation sequencing, a method that has revolutionized human genetics and medicine.

As a result of our involvement in this exciting area of research, Chemical & Engineering News recently asked Dr. Nathan Treff to weigh in on next generation technology to better select embryos and improve the success of IVF.

View an electronic version of the article HERE.